SI trades 20.1% below Wall Street's consensus target of $24.67.
Last 12 months price action with 12-month analyst target path
The base valuation assumes SI achieves its forward estimates and maintains a stable P/E multiple of historical averagesx. This scenario reflects the blended consensus of 4 Wall Street analysts, balancing both positive catalysts and macroeconomic headwinds over the next 12 months.
As of November 8, 2026, Shoulder Innovations, Inc. (SI) has a Wall Street consensus price target of $24.67, based on estimates from 4 covering analysts. With the stock currently trading at $20.54, this represents a potential upside of +20.1%. The company has a market capitalization of $426M.
Analyst price targets range from a low of $19.00 to a high of $28.00, representing a 36% spread in expectations. The median target of $27.00 differs from the mean, suggesting potential outlier estimates.
The current analyst consensus rating is Buy, with 4 analysts rating the stock as a Buy or Strong Buy,0 rating it Hold, and 0 rating it Sell or Strong Sell. This overwhelmingly bullish sentiment suggests analysts see significant catalysts for upside ahead.
From a valuation perspective, SI trades at a trailing P/E of -12.8x. Analysts expect EPS to grow -9.6% over the next year.
| Company | Market Cap | Price | Target | Upside Potential | Rating | Fwd P/E | Analysts |
|---|---|---|---|---|---|---|---|
 GMEDGlobus Medical, Inc. | $9.6B | $71.05 | $93.13 | +31.1% | Buy | 14.2x | 37 |
 ATECAlphatec Holdings, Inc. | $1.1B | $7.44 | $13.60 | +82.8% | Buy | 25.3x | 20 |
 XTNTXtant Medical Holdings, Inc. | $41M | $0.29 | — | — | — | — | — |
 NVCRNovocure Ltd | $1.5B | $13.28 | $26.00 | +95.8% | Buy | — | 15 |
 ZBHZimmer Biomet Holdings, Inc. | $20.4B | $105.59 | $109.11 | +3.3% | Hold | 12.4x | 42 |
 SYKStryker Corporation | $124.9B | $325.87 | $354.47 | +8.8% | Buy | 22.0x | 52 |
 JNJJohnson & Johnson | $664.9B | $276.22 | $285.31 | +3.3% | Buy | 24.9x | 40 |
 MDTMedtronic plc | $130.7B | $101.80 | $97.73 | -4.0% | Buy | 17.0x | 51 |
 BSXBoston Scientific Corporation | $63.5B | $42.75 | $54.65 | +27.8% | Buy | 13.5x | 44 |
 HSICHenry Schein, Inc. | $9.8B | $86.05 | $97.14 | +12.9% | Buy | 15.7x | 34 |
Quick answers to the most common questions about buying SI stock.
The consensus Wall Street price target for SI is $24.67, representing 20.1% upside from the current price of $20.54. With 4 analysts covering the stock, this strong upside suggests significant value not yet reflected in today's share price.
SI has a consensus rating of "Buy" based on 4 Wall Street analysts. The rating breakdown is predominantly bullish, with 4 Buy/Strong Buy ratings. The consensus 12-month price target of $24.67 implies 20.1% upside from current levels.
SI's current price is $20.54 with a consensus target of $24.67 (20.1% implied move). Analyst estimates suggest the stock is undervalued at current levels.
The most bullish Wall Street analyst has a price target of $28 for SI, while the most conservative target is $19. The consensus of $24.67 represents the median expectation. These targets typically reflect 12-month expectations.
SI is lightly followed, with 4 analysts providing price targets and ratings. Of these, 0 have Strong Buy ratings, 4 have Buy ratings, 0 recommend Hold, and 0 have Sell or Strong Sell ratings. Higher analyst coverage generally indicates greater institutional interest and more reliable consensus estimates.
The 12-month SI stock forecast based on 4 Wall Street analysts shows a consensus price target of $24.67, with estimates ranging from $19 (bear case) to $28 (bull case). The median consensus rating is "Buy".
Wall Street analysts are very optimistic on SI, with a "Buy" consensus rating and $24.67 price target (20.1% upside). 4 of 4 analysts rate it Buy or Strong Buy. This information is for educational purposes only. Always conduct your own research, consider your financial situation, and consult a financial advisor before making investment decisions.
SI analyst price targets range from $19 to $28, a 36% moderate spread showing some variance in outlooks. Differences stem from varying assumptions about revenue growth, profit margins, competitive dynamics, and valuation multiples. The $24.67 consensus represents the middle ground.
Live VCP patterns, Cup & Handle overlays, support/resistance, and AI trade plans.
High-probability breakout stocks crossing their pivot across 5 pattern engines.
DCF models, multiple analysis, and analyst estimates.
10-year return with dividends reinvested.
Compare growth, multiples, and margins vs sector.